A positive feedback loop of lncRNA-PVT1 and FOXM1 facilitates gastric cancer growth and invasion

Clinical Cancer Research

Volumn 23, Issue 8, 2017, Pages 2071-2080

  Xu, Mi Die ^a,b   Wang, Yiqin ^c   Weng, Weiwei ^a,b   Wei, Ping ^a,b   Qi, Peng ^a,b   Zhang, Qiongyan ^a,b   Tan, Cong ^a,b   Ni, Shu Juan ^a,b   Dong, Lei ^a,b   Yang, Yusi ^a,b   Lin, Wanrun ^a,b   Xu, Qinghua ^a,d   Huang, Dan ^a,b   Huang, Zhaohui ^e   Ma, Yuqing ^f   Zhang, Wei ^f   Sheng, Weiqi ^a,b   Du, Xiang ^a,b  

^a FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

^b FUDAN UNIVERSITY   (China)

^c OBSTETRICS AND GYNECOLOGY HOSPITAL OF FUDAN UNIVERSITY   (China)

^d Canhelp Genomics   (China)

^e JIANGNAN UNIVERSITY   (China)

^f XINJIANG MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIOTIN; FORKHEAD BOX PROTEIN M1; LONG UNTRANSLATED RNA; LUCIFERASE; NOP2 PROTEIN; NUCLEAR PROTEIN; UNCLASSIFIED DRUG; FOXM1 PROTEIN, HUMAN; PVT1 LONG-NON-CODING RNA, HUMAN;

ARTICLE; CANCER GROWTH; CANCER PROGNOSIS; CANCER STAGING; CELL INVASION; CELL PROLIFERATION; CHEMICAL BINDING; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DNA TRANSCRIPTION; GENE EXPRESSION; GENE MUTATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY; LUCIFERASE ASSAY; MAJOR CLINICAL STUDY; ONCOGENE C MYB; PLASMID; POSITIVE FEEDBACK; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPRODUCIBILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CANCER; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; BIOSYNTHESIS; DISEASE FREE SURVIVAL; GENE EXPRESSION REGULATION; GENETICS; KAPLAN MEIER METHOD; MASS SPECTROMETRY; MORTALITY; PATHOLOGY; PHYSIOLOGICAL FEEDBACK; PROPORTIONAL HAZARDS MODEL; STOMACH TUMOR; TUMOR INVASION; UPREGULATION; WESTERN BLOTTING;

BLOTTING, WESTERN; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; DISEASE-FREE SURVIVAL; FEEDBACK, PHYSIOLOGICAL; FORKHEAD BOX PROTEIN M1; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KAPLAN-MEIER ESTIMATE; MASS SPECTROMETRY; NEOPLASM INVASIVENESS; PROPORTIONAL HAZARDS MODELS; RNA, LONG NONCODING; STOMACH NEOPLASMS; UP-REGULATION;

EID: 85018801287     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-16-0742     Document Type: Article

References (30)

1. Hamamoto Y. Complications in advanced or recurrent gastric cancer patients with peritoneal metastasis during and after palliative systemic chemotherapy. Mol Clin Oncol 2015;3:539-42.
2. Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, et al. Cancer statistics in China, 2015. CA Cancer J Clin 2016;66:115-32.
3. Tan P, Yeoh KG. Genetics and molecular pathogenesis of gastric adenocarcinoma. Gastroenterology 2015;149:1153-62.e3.
4. Sun M, Kraus WL. From discovery to function: The expanding roles of long noncoding RNAs in physiology and disease. Endocr Rev 2015;36:25-64.
5. Qi P, Xu MD, Shen XH, Ni SJ, Huang D, Tan C, et al. Reciprocal repression between TUSC7 and miR-23b in gastric cancer. Int J Cancer 2015;137: 1269-78.
6. Xu MD, Qi P, Weng WW, Shen XH, Ni SJ, Dong L, et al. Long non-coding RNA LSINCT5 predicts negative prognosis and exhibits oncogenic activity in gastric cancer. Medicine 2014;93:e303.
7. Cao WJ, Wu HL, He BS, Zhang YS, Zhang ZY. Analysis of long non-coding RNA expression profiles in gastric cancer. World J Gastroenterol 2013; 19:3658-64.
8. Ding J, Li D, Gong M, Wang J, Huang X, Wu T, et al. Expression and clinical significance of the long non-coding RNA PVT1 in human gastric cancer. OncoTargets Ther 2014;7:1625-30.
9. Kong R, Zhang EB, Yin DD, You LH, Xu TP, Chen WM, et al. Long noncoding RNA PVT1 indicates a poor prognosis of gastric cancer and promotes cell proliferation through epigenetically regulating p15 and p16. Mol Cancer 2015;14:82.
10. Wang F, Yuan JH, Wang SB, Yang F, Yuan SX, Ye C, et al. Oncofetal long noncoding RNA PVT1 promotes proliferation and stem cell-like property of hepatocellular carcinoma cells by stabilizing NOP2. Hepatology 2014;60: 1278-90.
11. Tseng YY, Moriarity BS, Gong W, Akiyama R, Tiwari A, Kawakami H, et al. PVT1 dependence in cancer with MYC copy-number increase. Nature 2014;512:82-6.
12. Raychaudhuri P, Park HJ. FoxM1: A master regulator of tumor metastasis. Cancer Res 2011;71:4329-33.
13. Wierstra I, Alves J. FOXM1, a typical proliferation-Associated transcription factor. Biol Chem 2007;388:1257-74.
14. Balli D, Zhang Y, Snyder J, Kalinichenko VV, Kalin TV. Endothelial cellspecific deletion of transcription factor FoxM1 increases urethane-induced lung carcinogenesis. Cancer Res 2011;71:40-50.
15. Katoh M, Igarashi M, Fukuda H, Nakagama H, Katoh M. Cancer genetics and genomics of human FOXfamily genes. Cancer Lett 2013;328:198-206.
16. Zeng J, Wang L, Li Q, Li W, Bjorkholm M, Jia J, et al. FoxM1 is up-regulated in gastric cancer and its inhibition leads to cellular senescence, partially dependent on p27 kip1. J Pathol 2009;218:419-27.
17. Cai H, Chen J, He B, Li Q, Li Y, Gao Y. A FOXM1 related long non-coding RNA contributes to gastric cancer cell migration. Mol Cell Biochem 2015;406:31-41.
18. Lauwers GY CF, Graham DY, Curado MP. Tumours of the stomach. In: Bosman FT CF, Hruban RH, Theise ND, editors. WHO classification of tumours of the digestive system. Lyon, France: WHO Press; 2010. p. 48-59.
19. Wang YQ, Xu MD, Weng WW, Wei P, Yang YS, Du X. BCL6 is a negative prognostic factor and exhibits pro-oncogenic activity in ovarian cancer. Am J Cancer Res 2015;5:255-66.
20. Xu MD, Dong L, Qi P, Weng WW, Shen XH, Ni SJ, et al. Pituitary tumortransforming gene-1 serves as an independent prognostic biomarker for gastric cancer. Gastric Cancer 2016;19:107-15.
21. Wei P, Zhang N, Wang Y, Li D, Wang L, Sun X, et al. FOXM1 promotes lung adenocarcinoma invasion and metastasis by upregulating SNAIL. Int J Biol Sci 2015;11:186-98.
22. Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, et al. The cBio cancer genomics portal: An open platform for exploring multidimensional cancer genomics data. Cancer Discov 2012;2:401-4.
23. Gao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, Sumer SO, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal 2013;6:pl1.
24. Maurizi M, Ferrandina G, Almadori G, Scambia G, Cadoni G, D'Agostino G, et al. Prognostic significance of methyl-p-hydroxy-phenyllactateesterase activity in laryngeal squamous cell carcinoma. Br J Cancer 1998;77:1253-9.
25. Qi P, Du X. The long non-coding RNAs, a new cancer diagnostic and therapeutic gold mine. Mod Pathol 2013;26:155-65.
26. Wang Y, Zhou X, Xu M, Weng W, Zhang Q, Yang Y, et al. OTUB1-catalyzed deubiquitination of FOXM1 facilitates tumor progression and predicts a poor prognosis in ovarian cancer. Oncotarget 2016;7:36681-97.
27. Carramusa L, Contino F, Ferro A, Minafra L, Perconti G, Giallongo A, et al. The PVT-1 oncogene is a Myc protein target that is overexpressed in transformed cells. J Cell Physiol 2007;213:511-8.
28. Blanco-Bose WE, Murphy MJ, Ehninger A, Offner S, Dubey C, Huang W, et al. C-Myc and its target FoxM1 are critical downstream effectors of constitutive androstane receptor (CAR) mediated direct liver hyperplasia. Hepatology 2008;48:1302-11.
29. Wierstra I, Alves J. FOXM1c transactivates the human c-myc promoter directly via the two TATA boxes P1 and P2. FEBS J 2006;273: 4645-67.
30. Kim SH, Joshi K, Ezhilarasan R, Myers TR, Siu J, Gu C, et al. EZH2 protects glioma stem cells from radiation-induced cell death in a MELK/FOXM1- dependent manner. Stem Cell Rep 2015;4:226-38.